| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.30M | - | |
| Other | 67.7K | $2.41M | - | |
| CFO | 40.3K | $1.44M | - | |
| Other | 34.6K | $1.23M | - | |
| Dir | 17.8K | $633.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $100.00 | $550,000.00 | -13.9% | |
| Aug 3, 2015 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 8,000 | $110.60 | $884,800.00 | -3.3% | |
| Jul 23, 2015 | Goddard Glenn83 | Senior Vice President, Finance | Sale+OE | 7,000 | $120.45 | $843,150.00 | -100% | |
| Jul 20, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $113.87 | $626,285.00 | -13.9% | |
| Jul 17, 2015 | Goddard Glenn83 | Senior Vice President, Finance | Sale+OE | 13,000 | $113.71 | $1,478,230.00 | -100% | |
| Jul 16, 2015 | Higgons John Duncan | Chief Operating Officer | Sale+OE | 20,000 | $114.02 | $2,280,400.00 | -14.1% | |
| Jul 16, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $114.28 | $1,108,924.60 | -1.5% | |
| Jun 25, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $105.13 | $1,020,157.26 | -1.5% | |
| Jun 15, 2015 | Higgons John Duncan | Chief Operating Officer | Sell | 7,000 | $105.23 | $736,610.00 | -5.4% | |
| Jun 8, 2015 | Biller Scott | Chief Scientific Officer | Sell | 5,500 | $121.85 | $670,175.00 | -12.9% |